DMBIO Y Trademark

Trademark Overview


On Thursday, December 19, 2013, a trademark application was filed for DMBIO Y with the United States Patent and Trademark Office. The USPTO has given the DMBIO Y trademark a serial number of 79148927. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Tuesday, December 19, 2023. This trademark is owned by Meiji Seika Pharma Co., Ltd.. The DMBIO Y trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations for the treatment of the central nervous system diseases, namely, psychiatric diseases, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, central nervous system neuropathic pain; pharmaceutical preparations for the treatment of the peripheral nervous system diseases, namely, poly neuropathy, facial paralysis, entrapment neuropathy, peripheral nervous system neuropathic pain; pharmaceutical preparations for the treatment of the sensory organs, namely, hearing loss, acute pain; pharmaceutical preparations for the treatment of cardiovascular diseases; pharmaceutical preparations for the treatment of the respiratory system; pharmaceutical preparations for use in gastroenteritis; pharmaceutical preparations of hormones for use in the treatment of infertility; pharmaceutical preparations for the treatment of genitourinary diseases, namely, infertility, inflammatory pelvic ...

Testing, inspection, research or development of pharmaceuticals; providing information relating to testing, inspection, research or development of pharmaceuticals; conducting clinical trials for pharmaceutical products
dmbio y

General Information


Serial Number79148927
Word MarkDMBIO Y
Filing DateThursday, December 19, 2013
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateTuesday, December 19, 2023
Registration Number4654830
Registration DateTuesday, December 16, 2014
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, September 30, 2014

Trademark Statements


Description of MarkThe mark consists of the wording "DMBIO Y". The letter "D" is in blue, the letter "M" is in red, and the letters "BIO" are in grey. The letter "Y" is to the upper right of "DMBIO" in the colors red, blue and grey.
Goods and ServicesPharmaceutical preparations for the treatment of the central nervous system diseases, namely, psychiatric diseases, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, central nervous system neuropathic pain; pharmaceutical preparations for the treatment of the peripheral nervous system diseases, namely, poly neuropathy, facial paralysis, entrapment neuropathy, peripheral nervous system neuropathic pain; pharmaceutical preparations for the treatment of the sensory organs, namely, hearing loss, acute pain; pharmaceutical preparations for the treatment of cardiovascular diseases; pharmaceutical preparations for the treatment of the respiratory system; pharmaceutical preparations for use in gastroenteritis; pharmaceutical preparations of hormones for use in the treatment of infertility; pharmaceutical preparations for the treatment of genitourinary diseases, namely, infertility, inflammatory pelvic diseases; pharmaceutical preparations for the treatment of urological diseases, namely, benign prostatic hyperplasia, over active bladder; pharmaceutical preparations for use in dermatology, namely, dermatitis, skin pigmentation diseases, acne medication; pharmaceutical preparations for the treatment of hematological diseases, namely, anemia; pharmaceutical preparations for the treatment of immunological diseases, namely, rejection in transplantation, autoimmune diseases, immunologic deficiency syndromes, allergy medication; vitamins; pharmaceutical preparations for the treatment of metabolic disorders; pharmaceutical preparations for the treatment of cancer
Indication of Colors claimedThe color(s) blue, red and grey is/are claimed as a feature of the mark.
Goods and ServicesTesting, inspection, research or development of pharmaceuticals; providing information relating to testing, inspection, research or development of pharmaceuticals; conducting clinical trials for pharmaceutical products

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, July 2, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, July 2, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameDM Bio Limited
Party Type31 - New Owner After Registration
Legal Entity Type99 - Other
AddressKR

Party NameMeiji Seika Pharma Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressTokyo 104-8002
JP

Party NameMeiji Seika Pharma Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressJP

Party NameMeiji Seika Pharma Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressJP

Trademark Events


Event DateEvent Description
Tuesday, July 22, 2014APPLICATION FILING RECEIPT MAILED
Friday, July 11, 2014SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, July 14, 2014LIMITATION FROM ORIGINAL APPLICATION ENTERED
Wednesday, July 16, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, July 16, 2014ASSIGNED TO EXAMINER
Monday, July 21, 2014NON-FINAL ACTION WRITTEN
Thursday, August 21, 2014TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, July 22, 2014NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, July 25, 2014REFUSAL PROCESSED BY MPU
Friday, July 25, 2014NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, August 11, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, August 11, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 11, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 12, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, August 16, 2014REFUSAL PROCESSED BY IB
Wednesday, August 20, 2014ASSIGNED TO LIE
Thursday, August 21, 2014ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, May 22, 2015FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, August 26, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, September 10, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 30, 2014PUBLISHED FOR OPPOSITION
Tuesday, September 30, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 16, 2014REGISTERED-PRINCIPAL REGISTER
Monday, March 16, 2015FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Thursday, May 7, 2015FINAL DISPOSITION PROCESSED
Thursday, May 7, 2015FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, March 2, 2022TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Thursday, March 9, 2017CHANGE OF OWNER RECEIVED FROM IB
Monday, December 16, 2019COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, July 2, 2021CANCELLED SECTION 71
Sunday, July 11, 2021REFUSAL PROCESSED BY IB
Sunday, August 29, 2021NOTIFICATION PROCESSED BY IB
Tuesday, January 24, 2023GENERIC MADRID TRANSACTION SENT TO IB
Monday, May 30, 2022FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, January 24, 2023GENERIC MADRID TRANSACTION CREATED
Tuesday, January 24, 2023INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Tuesday, July 16, 2024DEATH OF INTERNATIONAL REGISTRATION
Tuesday, July 16, 2024NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Tuesday, May 16, 2023FINAL DECISION TRANSACTION PROCESSED BY IB